FoxO1 mediates TGF-beta1-dependent cardiac myofibroblast differentiation

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1863, Issue 1, 2016, Pages 128-138

  Vivar, Raúl ^a,b   Humeres, Claudio ^b   Muñoz, Claudia ^b   Boza, Pía ^b   Bolivar, Samir ^b   Tapia, Felipe ^b   Lavandero, Sergio ^a,c   Chiong, Mario ^a   Diaz Araya, Guillermo ^a,b  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cardiac fibroblast; FoxO1; Myofibroblast, cell differentiation; TGF 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; PROCOLLAGEN; PROCOLLAGEN 1; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; CDKN1A PROTEIN, RAT; CYCLIN DEPENDENT KINASE INHIBITOR 1A; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, RAT; NERVE PROTEIN; TGFB1 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL CONTRACTION ASSAY; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSTASIS; DOWN REGULATION; GENE OVEREXPRESSION; HEART MUSCLE CELL; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; ACTIVE TRANSPORT; ANIMAL; BOVINE; CARDIAC MUSCLE; CELL CULTURE; CELL NUCLEUS; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SPRAGUE DAWLEY RAT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CATTLE; CELL DIFFERENTIATION; CELL NUCLEUS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; MYOCARDIUM; MYOFIBROBLASTS; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84946606314     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2015.10.019     Document Type: Article

References (67)

1. Yang L., Gao J.Y., Ma J., Xu X., Wang Q., Xiong L., Yang J., Ren J. Cardiac-specific overexpression of metallothionein attenuates myocardial remodeling and contractile dysfunction in l-NAME-induced experimental hypertension: role of autophagy regulation. Toxicol. Lett. 2015, 237:121-132.
2. Holditch S.J., Schreiber C.A., Nini R., Tonne J.M., Peng K.W., Geurts A., Jacob H.J., Burnett J.C., Cataliotti A., Ikeda Y. B-type natriuretic peptide deletion leads to progressive hypertension, associated organ damage, and reduced survival: novel model for human hypertension. Hypertension 2015, 66:199-210.
3. Zheng D., Dong S., Li T., Yang F., Yu X., Wu J., Zhong X., Zhao Y., Wang L., Xu C., Lu F., Zhang W. Exogenous hydrogen sulfide attenuates cardiac fibrosis through reactive oxygen species signal pathways in experimental diabetes mellitus models. Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol. 2015, 36:917-929.
4. Qiao W., Wang C., Chen B., Zhang F., Liu Y., Lu Q., Guo H., Yan C., Sun H., Hu G., Yin X. Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats. Cardiology 2015, 131:97-106.
5. Ju C.H., Wang X.P., Gao C.Y., Zhang S.X., Ma X.H., Liu C. Blockade of KCa3.1 attenuates left ventricular remodeling after experimental myocardial infarction. Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol. 2015, 36:1305-1315.
6. See F., Thomas W., Way K., Tzanidis A., Kompa A., Lewis D., Itescu S., Krum H. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat. J. Am. Coll. Cardiol. 2004, 44:1679-1689.
7. Petrov V.V., van Pelt J.F., Vermeesch J.R., Van Duppen V.J., Vekemans K., Fagard R.H., Lijnen P.J. TGF-beta1-induced cardiac myofibroblasts are nonproliferating functional cells carrying DNA damages. Exp. Cell Res. 2008, 314:1480-1494.
8. Leask A. Getting to the heart of the matter: new insights into cardiac fibrosis. Circ. Res. 2015, 116:1269-1276.
9. Shinzato T., Ohya Y., Nakamoto M., Ishida A., Takishita S. Beneficial effects of pioglitazone on left ventricular hypertrophy in genetically hypertensive rats. Hypertens. Res. Off. J. Jpn. Soc. Hypertens. 2007, 30:863-873.
10. Zhao W., Zhao T., Chen Y., Ahokas R.A., Sun Y. Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats. Mol. Cell. Biochem. 2008, 317:43-50.
11. Chen T., Li J., Liu J., Li N., Wang S., Liu H., Zeng M., Zhang Y., Bu P. Activation of SIRT3 by resveratrol ameliorates cardiac fibrosis and improves cardiac function via the TGF-beta/Smad3 pathway. Am. J. Physiol. Heart Circ. Physiol. 2015, 308:H424-H434.
12. Lei H., Wu D., Wang J.Y., Li L., Zhang C.L., Feng H., Fu F.Y., Wu L.L. C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation. Basic Res. Cardiol. 2015, 110:35.
13. Lu Y., Liu J.J., Bi X.Y., Yu X.J., Kong S.S., Qin F.F., Zhou J., Zang W.J. Pyridostigmine ameliorates cardiac remodeling induced by myocardial infarction via inhibition of the transforming growth factor-beta1/TGF-beta1-activated kinase pathway. J. Cardiovasc. Pharmacol. 2014, 63:412-420.
14. He Q., Zhou W., Xiong C., Tan G., Chen M. Lycopene attenuates inflammation and apoptosis in post-myocardial infarction remodeling by inhibiting the nuclear factor-kappaB signaling pathway. Mol. Med. Rep. 2015, 11:374-378.
15. Jiang F., Liu G.S., Dusting G.J., Chan E.C. NADPH oxidase-dependent redox signaling in TGF-beta-mediated fibrotic responses. Redox Biol. 2014, 2:267-272.
16. MacLean J., Pasumarthi K.B. Signaling mechanisms regulating fibroblast activation, phenoconversion and fibrosis in the heart. Indian J. Biochem. Biophys. 2014, 51:476-482.
17. Zeglinski M.R., Hnatowich M., Jassal D.S., Dixon I.M. SnoN as a novel negative regulator of TGF-beta/Smad signaling: a target for tailoring organ fibrosis. Am. J. Physiol. Heart Circ. Physiol. 2015, 308:H75-H82.
18. Chen G., Wang T., Uttarwar L., vanKrieken R., Li R., Chen X., Gao B., Ghayur A.A., Margetts P., Krepinsky J.C. SREBP-1 is a novel mediator of TGFbeta1 signaling in mesangial cells. J. Mol. Cell Biol. 2014, 6:516-530.
19. Oleggini R., Gastaldo N., Di Donato A. Regulation of elastin promoter by lysyl oxidase and growth factors: cross control of lysyl oxidase on TGF-beta1 effects. Matrix Biol. J. Int. Soc. Matrix Biol. 2007, 26:494-505.
20. Gomis R.R., Alarcon C., He W., Wang Q., Seoane J., Lash A., Massague J. A FoxO-Smad synexpression group in human keratinocytes. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:12747-12752.
21. Seoane J., Le H.V., Shen L., Anderson S.A., Massague J. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 2004, 117:211-223.
22. Chiribau C.B., Cheng L., Cucoranu I.C., Yu Y.S., Clempus R.E., Sorescu D. FOXO3A regulates peroxiredoxin III expression in human cardiac fibroblasts. J. Biol. Chem. 2008, 283:8211-8217.
23. Ronnebaum S.M., Patterson C. The FoxO family in cardiac function and dysfunction. Annu. Rev. Physiol. 2010, 72:81-94.
24. Matsuzaki H., Daitoku H., Hatta M., Tanaka K., Fukamizu A. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:11285-11290.
25. Duan X., Kong Z., Liu Y., Zeng Z., Li S., Wu W., Ji W., Yang B., Zhao Z., Zeng G. Beta-arrestin2 contributes to cell viability and proliferation via the down-regulation of FOXO1 in castration-resistant prostate cancer. J. Cell. Physiol. 2015, 230:2371-2381.
26. Lu N., Liu Y., Tang A., Chen L., Miao D., Yuan X. Hepatocyte-specific ablation of PP2A catalytic subunit alpha attenuates liver fibrosis progression via TGF-beta1/Smad signaling. BioMed. Res. Int. 2015, 2015:794862.
27. Han D.F., Zhang J.X., Wei W.J., Tao T., Hu Q., Wang Y.Y., Wang X.F., Liu N., You Y.P. Fenofibrate induces G0/G 1 phase arrest by modulating the PPARalpha/FoxO1/p27(kip) pathway in human glioblastoma cells. Tumour Biol. J. Int. Soc. Oncodev. Biol. Med. 2015, 36:3823-3829.
28. Liu F., Ma X.J., Wang Q.Z., Zhao Y.Y., Wu L.N., Qin G.J. The effect of FoxO1 on the proliferation of rat mesangial cells under high glucose conditions. Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transplant Assoc. Eur. Ren. Assoc. 2014, 29:1879-1887.
29. Palazuelos J., Klingener M., Aguirre A. TGFbeta signaling regulates the timing of CNS myelination by modulating oligodendrocyte progenitor cell cycle exit through SMAD3/4/FoxO1/Sp1. J. Neurosci. Off. J. Soc. Neurosci. 2014, 34:7917-7930.
30. Roy S., Khanna S., Rink T., Radtke J., Williams W.T., Biswas S., Schnitt R., Strauch A.R., Sen C.K. P21waf1/cip1/sdi1 as a central regulator of inducible smooth muscle actin expression and differentiation of cardiac fibroblasts to myofibroblasts. Mol. Biol. Cell 2007, 18:4837-4846.
31. Accornero F., van Berlo J.H., Correll R.N., Elrod J.W., Sargent M.A., York A., Rabinowitz J.E., Leask A., Molkentin J.D. Genetic analysis of connective tissue growth factor as an effector of transforming growth factor beta signaling and cardiac remodeling. Mol. Cell. Biol. 2015, 35:2154-2164.
32. 2-induced cardiac fibrosis via mediating Ca(2+) influx and extracellular signal-regulated kinase 1/2 (ERK1/2) activation in cardiac fibroblasts. J. Pharmacol. Sci. 2014, 125:184-192.
33. Akasaki Y., Hasegawa A., Saito M., Asahara H., Iwamoto Y., Lotz M.K. Dysregulated FOXO transcription factors in articular cartilage in aging and osteoarthritis, osteoarthritis and cartilage/OARS. Osteoarthr. Res. Soc. 2014, 22:162-170.
34. Ponugoti B., Xu F., Zhang C., Tian C., Pacios S., Graves D.T. FOXO1 promotes wound healing through the up-regulation of TGF-beta1 and prevention of oxidative stress. J. Cell Biol. 2013, 203:327-343.
35. Miyazono K. Tumour promoting functions of TGF-beta in CML-initiating cells. J. Biochem. 2012, 152:383-385.
36. Perrot V., Rechler M.M. The coactivator p300 directly acetylates the forkhead transcription factor Foxo1 and stimulates Foxo1-induced transcription. Mol. Endocrinol. 2005, 19:2283-2298.
37. Wondisford A.R., Xiong L., Chang E., Meng S., Meyers D.J., Li M., Cole P.A., He L. Control of Foxo1 gene expression by co-activator P300. J. Biol. Chem. 2014, 289:4326-4333.
38. Bugyei-Twum A., Advani A., Advani S.L., Zhang Y., Thai K., Kelly D.J., Connelly K.A. High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy. Cardiovasc. Diabetol. 2014, 13:89.
39. Ni J., Shen Y., Wang Z., Shao D.C., Liu J., Kong Y.L., Fu L.J., Zhou L., Xue H., Huang Y., Zhang W., Yu C., Lu L.M. P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells. Acta Pharmacol. Sin. 2014, 35:1157-1166.
40. Zhang C., Ponugoti B., Tian C., Xu F., Tarapore R., Batres A., Alsadun S., Lim J., Dong G., Graves D.T. FOXO1 differentially regulates both normal and diabetic wound healing. J. Cell Biol. 2015, 209:289-303.
41. Scheimann A.O., Durham S.K., Suwanichkul A., Snuggs M.B., Powell D.R. Role of three FKHR phosphorylation sites in insulin inhibition of FKHR action in hepatocytes. Horm. Metab. Res. Horm. Stoffwechselforschung Horm Metab. 2001, 33:631-638.
42. Skarra D.V., Thackray V.G. FOXO1 is regulated by insulin and IGF1 in pituitary gonadotropes. Mol. Cell. Endocrinol. 2015, 405:14-24.
43. Hall J.A., Tabata M., Rodgers J.T., Puigserver P. USP7 attenuates hepatic gluconeogenesis through modulation of FoxO1 gene promoter occupancy. Mol. Endocrinol. 2014, 28:912-924.
44. Liu Z.Q., Shen M., Wu W.J., Li B.J., Weng Q.N., Li M., Liu H.L. Expression of PUMA in follicular granulosa cells regulated by FoxO1 activation during oxidative stress. Reprod. Sci. 2015, 22:696-705.
45. Qi Y., Zhu Q., Zhang K., Thomas C., Wu Y., Kumar R., Baker K.M., Xu Z., Chen S., Guo S. Activation of Foxo1 by insulin resistance promotes cardiac dysfunction and beta-myosin heavy chain gene expression. Circ. Heart Fail. 2015, 8:198-208.
46. Arden K.C. FoxO: linking new signaling pathways. Mol. Cell 2004, 14:416-418.
47. Tanaka H., Murakami Y., Ishii I., Nakata S. Involvement of a forkhead transcription factor, FOXO1A, in UV-induced changes of collagen metabolism, The journal of investigative dermatology. Symposium Proceedings/the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research 2009, 14:60-62.
48. Samarin J., Cicha I., Goppelt-Struebe M. Cell type-specific regulation of CCN2 protein expression by PI3K-AKT-FoxO signaling. J. Cell Commun. Signal. 2009, 3:79-84.
49. Yang H., Zhan L., Yang T., Wang L., Li C., Zhao J., Lei Z., Li X., Zhang H.T. Ski prevents TGF-beta-induced EMT and cell invasion by repressing SMAD-dependent signaling in non-small cell lung cancer. Oncol. Rep. 2015, 34:87-94.
50. Ha B., Lee E.B., Cui J., Kim Y., Jang H.H. YB-1 overexpression promotes a TGF-beta1-induced epithelial-mesenchymal transition via Akt activation. Biochem. Biophys. Res. Commun. 2015, 458:347-351.
51. Wang J.Y., Gao Y.B., Zhang N., Zou D.W., Wang P., Zhu Z.Y., Li J.Y., Zhou S.N., Wang S.C., Wang Y.Y., Yang J.K. miR-21 overexpression enhances TGF-beta1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Mol. Cell. Endocrinol. 2014, 392:163-172.
52. Chen Z., Li W., Ning Y., Liu T., Shao J., Wang Y. Ski diminishes TGF-beta1-induced myofibroblast phenotype via up-regulating Meox2 expression. Exp. Mol. Pathol. 2014, 97:542-549.
53. Yan X., Zhang J., Pan L., Wang P., Xue H., Zhang L., Gao X., Zhao X., Ning Y., Chen Y.G. TSC-22 promotes transforming growth factor beta-mediated cardiac myofibroblast differentiation by antagonizing Smad7 activity. Mol. Cell. Biol. 2011, 31:3700-3709.
54. Jopling C., Sleep E., Raya M., Marti M., Raya A., Izpisua Belmonte J.C. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature 2010, 464:606-609.
55. Driesen R.B., Nagaraju C.K., Abi-Char J., Coenen T., Lijnen P.J., Fagard R.H., Sipido K.R., Petrov V.V. Reversible and irreversible differentiation of cardiac fibroblasts. Cardiovasc. Res. 2014, 101:411-422.
56. Rosenkranz S. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc. Res. 2004, 63:423-432.
57. Strutz F., Zeisberg M., Renziehausen A., Raschke B., Becker V., van Kooten C., Muller G. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int. 2001, 59:579-592.
58. Zhang X., Tang N., Hadden T.J., Rishi A.K., Akt FoxO and regulation of apoptosis. Biochim. Biophys. Acta 2011, 1813:1978-1986.
59. Terada Y., Okado T., Inoshita S., Hanada S., Kuwahara M., Sasaki S., Yamamoto T., Marumo F. Glucocorticoids stimulate p21 (CIP1) in mesangial cells and in anti-GBM glomerulonephritis. Kidney Int. 2001, 59:1706-1716.
60. Lijnen P., Petrov V., Fagard R. Transforming growth factor-beta 1-mediated collagen gel contraction by cardiac fibroblasts. J. Renin-Angiotensin-Aldosterone Syst. 2003, 4:113-118.
61. Bujak M., Frangogiannis N.G. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc. Res. 2007, 74:184-195.
62. Dobaczewski M., Bujak M., Li N., Gonzalez-Quesada C., Mendoza L.H., Wang X.F., Frangogiannis N.G. Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ. Res. 2010, 107:418-428.
63. Xiao E., Graves D.T. Impact of diabetes on the protective role of FOXO1 in wound healing. J. Dent. Res. 2015, 94:1025-1026.
64. Francois H., Athirakul K., Howell D., Dash R., Mao L., Kim H.S., Rockman H.A., Fitzgerald G.A., Koller B.H., Coffman T.M. Prostacyclin protects against elevated blood pressure and cardiac fibrosis. Cell Metab. 2005, 2:201-207.
65. Ichiki T., Schirger J.A., Huntley B.K., Brozovich F.V., Maleszewski J.J., Sandberg S.M., Sangaralingham S.J., Park S.J., Burnett J.C. Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications. J. Mol. Cell. Cardiol. 2014, 75:199-205.
66. Lee J.W., Chen H., Pullikotil P., Quon M.J. Protein kinase A-alpha directly phosphorylates FoxO1 in vascular endothelial cells to regulate expression of vascular cellular adhesion molecule-1 mRNA. J. Biol. Chem. 2011, 286:6423-6432.
67. Shen M., Liu Z., Li B., Teng Y., Zhang J., Tang Y., Sun S.C., Liu H. Involvement of FoxO1 in the effects of follicle-stimulating hormone on inhibition of apoptosis in mouse granulosa cells. Cell Death Dis. 2014, 5.